Diaminodiacid Bridges to Improve Folding and Tune the Bioactivity of Disulfide‐Rich Peptides
- 1 June 2015
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 54 (48) , 14276-14281
Abstract
Disulfide‐rich peptides containing three or more disulfide bonds are promising therapeutic and diagnostic agents, but their preparation is often limited by the tedious and low‐yielding folding process. We found that a single cystine‐to‐diaminodiacid replacement could significantly increase the folding efficiency of disulfide‐rich peptides and thus improve their production yields. The practicality of this strategy was demonstrated by the synthesis and folding of derivatives of the μ‐conotoxin SIIIA, the preclinical hormone hepcidin, and the trypsin inhibitor EETI‐II. NMR and X‐ray crystallography studies confirmed that these derivatives of disulfide‐rich peptide retained the correct three‐dimensional conformations. Moreover, the cystine‐to‐diaminodiacid replacement enabled structural tuning, thereby leading to an EETI‐II derivative with higher bioactivity than the native peptide.Keywords
Funding Information
- “863” Program of the Ministry of Science and Technology (2012AA02A700)
- National Basic Research Program of China (2013CB932800, 2015CB910100)
- NSFC (91313301, 21225207)
- Specialized Research Fund for the Doctoral Program of Higher Education (20120002130004)
This publication has 54 references indexed in Scilit:
- Multifaceted Roles of Disulfide Bonds. Peptides as TherapeuticsChemical Reviews, 2013
- Pharmacologic Properties, Metabolism, and Disposition of Linaclotide, a Novel Therapeutic Peptide Approved for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic ConstipationThe Journal of Pharmacology and Experimental Therapeutics, 2013
- Chemical Synthesis of Circular ProteinsJournal of Biological Chemistry, 2012
- Turbo-charged crosslinkingNature Chemistry, 2012
- Knottins: disulfide-bonded therapeutic and diagnostic peptidesDrug Discovery Today: Technologies, 2012
- Synthetic therapeutic peptides: science and marketDrug Discovery Today, 2010
- Integrating the discovery pipeline for novel compounds targeting ion channelsCurrent Opinion in Chemical Biology, 2008
- Chemical Modification of Conotoxins to Improve Stability and ActivityACS Chemical Biology, 2007
- Thermal, Chemical, and Enzymatic Stability of the Cyclotide Kalata B1: The Importance of the Cyclic Cystine KnotBiochemistry, 2004
- Therapeutic potential of venom peptidesNature Reviews Drug Discovery, 2003